omniture
logo
Search
雅创医药技术（上海）有限公司 HEPAGENE
Media Room

Latest News

rss

Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist

HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical...

2023-09-20 22:00 1478

Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023

SHANGHAI, May 25, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc., a clinical stage biopharmaceuti...

2023-05-25 22:00 2025

Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH

SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical stage biopharmaceut...

2023-01-19 23:00 2454

Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH

SHANGHAI, Dec. 2, 2021 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage biopharmaceutic...

2021-12-02 23:00 1583

Hepagene Therapeutics, Inc. Announces Positive Results from Phase I Trial of HPG1860

SHANGHAI, Aug. 23, 2021 /PRNewswire/ -- Hepagene Therapeutics, Inc., a clinical stage biopharmaceut...

2021-08-23 22:00 1436